Irritable Bowel Syndrome (IBS): Symptoms, Causes, and Evidence-Based Treatments

ByAdmin

Meta Description: What is IBS? Learn the symptoms, types, causes, diagnosis criteria, and most effective evidence-based dietary and lifestyle treatments for Irritable Bowel Syndrome.

What Is IBS?

Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder characterized by chronic or recurrent abdominal pain associated with altered bowel habits — diarrhea, constipation, or alternating patterns — in the absence of any structural, inflammatory, or biochemical explanation detectable by standard testing.

IBS affects an estimated 10–15% of the global population, making it one of the most prevalent gastrointestinal diagnoses worldwide. It is more common in women (2:1 female:male ratio) and typically presents before age 50. Despite causing significant quality-of-life impairment, IBS carries no increased risk of serious disease or reduced lifespan.

Types of IBS

  • IBS-D (diarrhea-predominant): Loose stools, urgency, frequent bowel movements. More common in men.
  • IBS-C (constipation-predominant): Infrequent, hard stools, straining, incomplete evacuation. More common in women.
  • IBS-M (mixed): Alternates between diarrhea and constipation.
  • IBS-U (unsubtyped): Does not meet criteria for D, C, or M classification.

IBS Symptoms

  • Recurrent abdominal pain or cramping (at least 1 day per week for the past 3 months)
  • Pain associated with bowel movements (relieved or worsened by defecation)
  • Changes in stool frequency (more or less frequent than normal)
  • Changes in stool form (hard/lumpy or loose/watery)
  • Bloating and abdominal distension
  • Excess gas (flatulence)
  • Mucus in stool
  • Sensation of incomplete evacuation

What Causes IBS?

IBS is a multi-factorial disorder. Key underlying mechanisms include:

  • Gut dysbiosis: Altered microbiome composition with reduced diversity and lower levels of butyrate-producing bacteria is consistently observed.
  • Visceral hypersensitivity: Abnormally heightened pain perception in the gut (the gut’s “pain volume dial” is turned up), causing normal digestive sensations to be perceived as painful.
  • Gut-brain axis dysregulation: Abnormal communication between the enteric nervous system and the central nervous system contributes to altered gut motility and pain processing.
  • Post-infectious IBS: 10–15% of IBS cases develop after acute gastroenteritis (food poisoning or gut infection). Bacterial or viral infection can trigger persistent dysbiosis and immune activation.
  • SIBO: Small intestinal bacterial overgrowth is present in a significant subset of IBS patients and may drive symptoms.
  • Intestinal permeability: Increased tight junction permeability observed in IBS-D.
  • Psychological factors: Anxiety, depression, and childhood adversity are strongly associated with IBS — reflecting gut-brain axis bidirectionality.

Diagnosis of IBS: Rome IV Criteria

IBS is a clinical diagnosis based on the Rome IV criteria. A diagnosis requires recurrent abdominal pain, on average at least 1 day per week in the last 3 months, associated with two or more of: relation to defecation, change in stool frequency, change in stool form/appearance. Onset must have been at least 6 months prior to diagnosis.

Red flag symptoms requiring investigation before IBS diagnosis: rectal bleeding, unintentional weight loss, nocturnal symptoms, family history of colorectal cancer or IBD, onset after age 50, and iron deficiency anemia.

Evidence-Based Treatments for IBS

Low-FODMAP Diet (Strongest Dietary Evidence)

The low-FODMAP diet — developed at Monash University — restricts fermentable oligosaccharides, disaccharides, monosaccharides, and polyols that are poorly absorbed in the small intestine and rapidly fermented by gut bacteria, causing gas, bloating, and diarrhea in sensitive individuals. Approximately 70% of IBS patients report symptom improvement on a low-FODMAP diet. The restriction phase (2–6 weeks) is followed by systematic reintroduction to identify individual triggers.

Probiotics

Multiple probiotic strains show modest but consistent benefits for IBS symptom reduction, particularly for bloating, pain, and bowel regularity. Most studied: Bifidobacterium infantis 35624, VSL#3 (Visbiome), and Lactobacillus acidophilus NCFM.

Gut-Directed Hypnotherapy

One of the most effective non-pharmacological treatments for IBS with a strong evidence base — comparable to the low-FODMAP diet. Approximately 70% of patients show clinically meaningful improvement. Works by reducing visceral hypersensitivity and normalizing gut-brain axis communication.

Cognitive Behavioral Therapy (CBT)

IBS-specific CBT addresses catastrophizing, avoidance behaviors, and the psychological amplification of gut symptoms. Multiple RCTs demonstrate significant symptom reduction and improved quality of life.

Peppermint Oil

Enteric-coated peppermint oil capsules have strong evidence (multiple meta-analyses) for reducing IBS abdominal pain. Menthol, the active compound, relaxes smooth muscle in the gut, reducing spasms. Typical dose: 0.2–0.4ml 3x/day before meals.

FAQ

Is IBS the same as IBD?

No — they are distinct conditions. IBS is a functional disorder with no measurable inflammation or tissue damage. IBD (Crohn’s disease and ulcerative colitis) involves chronic immune-mediated inflammation with structural damage to the gut wall, visible on colonoscopy and measurable in blood and stool tests. IBD carries risk of complications including strictures, fistulas, and colorectal cancer; IBS does not.

What foods should I avoid with IBS?

Triggers vary significantly between individuals, which is why the structured low-FODMAP reintroduction protocol is recommended over simply avoiding a generic list. Common triggers include: high-FODMAP foods (onions, garlic, apples, wheat, lactose), fatty foods, caffeine, alcohol, and carbonated beverages. Keeping a symptom diary during reintroduction identifies your personal triggers.